PROGRESSIVE GAIT INSTABILITY AND INTRACRANIAL LESIONS OF UNKNOWN ETIOLOGY IN STAT1 GOF MUTATION

被引：0
|
作者：
Biswas, L.
Lawrence, M.
Heinan, K.
Koroulakis, D.
Berry, D.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M240
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [21] Disseminated Histoplasmosis in an Adult with STAT1 Mutation
    Nimri, Sarah
    Davis, Benjamin
    Dowden, Amy
    Bayer, Diana K.
    CLINICAL IMMUNOLOGY, 2024, 262
  • [22] Jakinibs in the Immunodysregulation in Patients with Gain of Function (GOF) STAT1 or STAT3 Mutations - An International Experience
    Forbes, Lisa R.
    Cooper, Megan A.
    Castro-Wagner, Johana
    Vogel, Tiphanie P.
    Schussler, Edith
    Su, Helen
    Slatter, Mary
    Cunningham-Rundles, Charlotte
    Eckstein, Olive
    Freeman, Alexandra
    Zerbe, Crista S.
    Holland, Steven M.
    Szabolcs, Paul
    Weinacht, Katja G.
    Plant, Ashley
    Gennery, Andrew
    Torgerson, Troy
    Milner, Joshua D.
    Leiding, Jennifer W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S1 - S1
  • [23] Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients
    Bloomfield, Marketa
    Parackova, Zuzana
    Hanzlikova, Jana
    Lastovicka, Jan
    Sediva, Anna
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (02) : 266 - 269
  • [24] Functional Natural Killer (NK) Cell Deficiency in Patients with Signal Transducer and Activator of Transcription (STAT1) Gain of Function Mutation (GOF)
    Forbes, L. R.
    Vargas-Hernandez, A.
    Mace, E. M.
    Free-Man, A. F.
    Rosenzweig, S.
    Holland, S. M.
    Orange, J. S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S339 - S339
  • [25] RUXOLITINIB USE IN A CHILD WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS AND AUTOSOMAL DOMINANT SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 GAIN OF FUNCTION (STAT1 GOF) MUTATION
    Chan, D.
    King, J.
    Dzeladini, L.
    Marchand, B.
    Gold, M.
    Quinn, P.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 28
  • [26] DELAYED DIAGNOSIS OF STAT1 GOF WITH RECURRENT PNEUMONIA DUE TO ABSENT FUNGAL INFECTIONS AT PRESENTATION
    Brooks, C.
    Redmond, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S90 - S90
  • [27] Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF
    Koh, June-Young
    Kim, Doo Ri
    Son, Sohee
    Park, Hwanhee
    Kim, Kyung-Ran
    Min, Sunwoo
    Lee, Ha Seok
    Jhun, Byung Woo
    Kang, Eun-Suk
    Jung, Inkyung
    Kang, Ji-Man
    Kim, Yae-Jean
    Shin, Eui-Cheol
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (04)
  • [28] Disseminated Nannizziopsis Infection in an Adolescent With a STAT1 Mutation
    Most, Zachary M.
    Lieu, Tiffany
    Filkins, Laura
    Nicolaides, Rory
    Rakheja, Dinesh
    Gelfand, Andrew
    Kahn, Jeffrey
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (09):
  • [29] Novel Presentation of STAT1 Gain of Function (GOF) with Specific Antibody Deficiency without Fungal Infection
    Gharfeh, Maya
    Vargas-Hernandez, Alexander
    Chinn, Ivan K.
    Hanson, I. Celine
    Forbes, Lisa R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB217 - AB217
  • [30] STAT1 GOF DISEASE PRESENTING WITH RECURRENT CUTANEOUS CELLULITIS AND UNREMARKABLE BASIC IMMUNOLOGY LABORATORY VALUES
    Desai, S.
    Gebbia, J.
    Kleiner, G.
    Gans, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S141 - S142
12345